logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 서울중앙지방법원 2019.11.21 2018가단5006702
손해배상(의)
Text

1. The Defendants jointly share KRW 9,428,571, and KRW 6,285,714, respectively, to Plaintiff A and the Plaintiff B and C, as well as their respective amount.

Reasons

1. Basic facts

A. The Plaintiffs are the successors of the deceased F (the deceased on November 26, 2017, hereinafter “the deceased”). Defendant E is the pulmonary patients of G Hospital (hereinafter “Defendant Hospital”) who treated the Deceased, and the Defendant School Foundation D (hereinafter “Defendant Corporation”) is a juristic person operating the Defendant Hospital.

B. In 2007, the Deceased was diagnosed by the Defendant Hospital as a special pulmonary fiber, and was under the chest CT examination at the Defendant Hospital every one to two years, and the chest CT examination conducted on January 12, 2017 was confirmed that there was a growing outcome of the fluoral pulmonary pulmonary pulmonary pulmonary pulmonary pulmonary pulmonary pulmonary pulmonary pulmonary pulmonary Elimination.

Defendant E planned to conduct a tracking inspection six months after the conclusion of left leaves.

C. The Defendant Hospital’s chest CT test conducted on June 29, 2017 conducted on the deceased’s chest CT test conducted by the Defendant Hospital increased the fluority of left leaves more than January 2, 2017, and the fluorization was unfolded.

The medical specialist of the film department of the defendant hospital recommended the examination of Cho Young River CT for the identification of sacratization.

On July 21, 2017, Defendant E was given outpatient medical treatment to the Deceased, and did not conduct an additional inspection, such as Cho Young River CT inspection, and planned tracking CT inspection around December 2017, which was six months later.

E. Around November 2, 2017, the Deceased applied to the Defendant Hospital for symptoms, such as parassis and respiratory distress, etc., and the Defendant Hospital conducted a chest CT test against the Deceased.

As a result of the CT test, the Defendant hospital was found to have increased the left fluority, and there seems to be a fluorant opinion. On November 6, 2017, the Defendant hospital conducted a closed tissue test and the PET CT test with respect to the Deceased, and diagnosed it as a small cell waste cancer transferred to another long term.

F. The Deceased discharged on November 13, 2017, and was hospitalized in the Defendant Hospital again through an emergency room on November 20, 2017, and on November 22, 2017, the low oxygen respiratory part caused by a smokingr occurred, and transferred to a intensive treatment room on November 26, 2017, and died of the pulmonary collection on November 26, 2017.

[Ground of recognition] Unsatisfy, Gap evidence 3, 4, and Eul.

arrow